71715-002 : Nuzyra 150 mg Oral Tablet, Film Coated
| NDC: | 71715-002 |
| Labeler: | Paratek Pharmaceuticals, Inc. |
| Product Type: | Human Prescription Drug |
| Drug Name: |  Nuzyra |
| Dosage Form: | Oral Tablet, Film Coated |
| Application #: | NDA209816 |
| Rev. Date: |
Appearance:
| Markings: | OMC;150 |
| Shapes: |
Diamond (4 sides) |
| Colors: |
 Yellow |
| Size (mm): | 19 |
| Segments: * | 1 |
* Segments = the number of equally sized pieces which the pill can be broken into. In this case, a value of 1 indicates a solid pill with no score lines. | |
NDC Package Codes:
- 71715-002-21: 1 BLISTER PACK IN 1 CARTON (71715‑002‑21) > 6 TABLET, FILM COATED IN 1 BLISTER PACK
- 71715-002-23: 14 TABLET, FILM COATED IN 1 BLISTER PACK (71715‑002‑23)
- 71715-002-24: 16 TABLET, FILM COATED IN 1 BLISTER PACK (71715‑002‑24)
- 71715-002-27: 5 BLISTER PACK IN 1 CARTON (71715‑002‑27) > 6 TABLET, FILM COATED IN 1 BLISTER PACK (71715‑002‑28)
Active Ingredients:
- Omadacycline
Dosage Strength:
- 150 mg
Inactive Ingredients:
- Silicon Dioxide
- Crospovidone
- Glyceryl Monocaprylocaprate
- Ferric Oxide Yellow
- Lactose Monohydrate
- Microcrystalline Cellulose
- Polyvinyl Alcohol, Unspecified
- Sodium Bisulfite
- Sodium Lauryl Sulfate
- Sodium Stearyl Fumarate
- Talc
- Titanium Dioxide /
Pharmaceutical Classes:
- Tetracycline-class Antibacterial [EPC]
- Tetracyclines [CS]
Related Products:
Based on records with the same trade name.- 71715-001 Nuzyra 100 mg/5ml Intravenous Injection, Powder, Lyophilized, for Solution by Paratek Pharmaceuticals, Inc.
NDC QR Code
Scan the QR code below to easily reference this data in the future:
< Prev: 71715-001Next: 71717-101 >
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.